美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

OnKure Therapeutics, Inc.

2.67

-0.0950-3.44%

成交量：16.93万

成交额：44.99万

市值：3,580.65万

市盈率：-0.17

高：2.81

开：2.67

低：2.54

收：2.76

数据加载中...

总览公司新闻公告

HC Wainwright & Co.：维持OnKure Therapeutics评级

美国研究综述-美国电力公司、布洛克公司、伦茨治疗公司

Onkure Therapeutics, Inc.2024财年实现净利润-52.67百万美元，同比增加31.94%

奥本海默：维持OnKure Therapeutics(OKUR.US)评级，由优于大市调整至优于大市评级, 目标价由35.00美元调整至30.00美元。

OnKure Therapeutics(OKUR.US)：2024年Q4财报实现营收0美元；每股收益为-1.37美元，前值为-30.14美元，预期值为-0.74美元。

OnKure Therapeutics 2024年第四季度GAAP每股收益$(1.37)未达到$(0.74)的预期

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/OKUR/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OKUR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OKUR\",,,,,undefined,":{"symbol":"OKUR","market":"US","secType":"STK","nameCN":"OnKure Therapeutics, Inc.","latestPrice":2.665,"timestamp":1745518584858,"preClose":2.76,"halted":0,"volume":169332,"delay":0,"floatShares":4257469,"shares":13435826,"eps":-15.280509,"marketStatus":"交易中","change":-0.095,"latestTime":"04-24 14:25:59 EDT","open":2.67,"high":2.81,"low":2.54,"amount":449943.67337519996,"amplitude":0.097826,"askPrice":2.68,"askSize":19,"bidPrice":2.66,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-15.280509,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1745524800000},"marketStatusCode":2,"adr":0,"listingDate":1617940800000,"exchange":"NASDAQ","adjPreClose":2.76,"postHourTrading":{"tag":"盘后","latestPrice":2.76,"preClose":2.76,"latestTime":"17:33 EDT","volume":210,"amount":583.516,"timestamp":1745444021070},"volumeRatio":2.925509},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OKUR\",,,,,undefined,":{"symbol":"OKUR","floatShares":4257469,"roa":"-44.43%","roe":"-79.92%","lyrEps":-15.280509,"volumeRatio":2.925509,"shares":13435826,"dividePrice":0,"high":2.81,"amplitude":0.097826,"preClose":2.76,"low":2.54,"week52Low":2.5,"pbRate":"0.34","week52High":190,"institutionHeld":0,"latestPrice":2.665,"committee":0.826484,"eps":-15.280509,"divideRate":0,"volume":169332,"delay":0,"ttmEps":-15.280509,"open":2.67,"prevYearClose":8.6,"prevWeekClose":2.89,"prevMonthClose":4.3,"prevQuarterClose":4.3,"fiveDayClose":2.93,"twentyDayClose":4.74,"sixtyDayClose":5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OKUR\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520620847","title":"HC Wainwright & Co.：维持OnKure Therapeutics评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2520620847","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520620847?lang=zh_cn&edition=fundamental","pubTime":"2025-03-18 19:39","pubTimestamp":1742297960,"startTime":"0","endTime":"0","summary":"HC Wainwright&Co.：维持OnKure Therapeutics(OKUR.US)评级，由买入调整至买入评级,目标价由40.00美元调整至34.00美元。OnKure Therapeutics(OKUR.US)公司简介：OnKure Therapeutics Inc是一家处于临床阶段的生物制药公司，致力于发现和开发顶级精准药物，靶向现有疗法无法治疗的，经生物学验证的癌症驱动因素。该公司拥有一条肿瘤诊断候选药物管线，旨在达到最佳疗效和耐受性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318194513a438329f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318194513a438329f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OKUR","LENZ"],"gpt_icon":0},{"id":"2520903623","title":"美国研究综述-美国电力公司、布洛克公司、伦茨治疗公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2520903623","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520903623?lang=zh_cn&edition=fundamental","pubTime":"2025-03-18 19:03","pubTimestamp":1742295828,"startTime":"0","endTime":"0","summary":"美国研究综述-美国电力公司、布洛克公司、伦茨治疗公司路透3月18日 - 华尔街证券分析师周二调整了对美国电力公司、Block Inc 和 Lenz Therapeutics 等几家美国上市公司的评级和目标价。要闻  * 美国电力公司AEP.O：摩根大通将该公司的股票交易价格从98美元上调至107美元  * Block Inc XYZ.N：KBW将其评级从 \"市场表现 \"上调至 \"跑赢大盘\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nL4S3Q10R2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2552382215.SGD","AROC","APLS","AEP","BK4077","LNG","LU2361044865.SGD","ALK","LCID","FIVE","AXP","AMT","HRMY","STZ","CCI","IE0005OL40V9.USD","IE00BFMHRM44.USD","LU1267930490.SGD","LU0006061336.USD","MGX","CNX","DLR","BE","GEV","EQT","INCY","GRAL","EXE","GETY","HWC","BDTX","OKUR","BK4099","FDX","HAE","LENZ","LEN","IE0004445015.USD","ALGN","EU","XYZ","DAL","GBTG","LU0788109394.HKD","EWBC","AM"],"gpt_icon":1},{"id":"2518408773","title":"Onkure Therapeutics, Inc.2024财年实现净利润-52.67百万美元，同比增加31.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518408773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518408773?lang=zh_cn&edition=fundamental","pubTime":"2025-03-12 11:02","pubTimestamp":1741748572,"startTime":"0","endTime":"0","summary":"3月12日，Onkure Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-52.67百万美元，同比增加31.94%；其中营业收入为0.00美元，每股基本收益为-3.95美元。从资产负债表来看，Onkure Therapeutics, Inc.总负债11.08百万美元，其中短期债务536000.00美元，资产负债比为0.11，流动比率为0.11。机构评级：截至2025年3月12日，当前有4家机构对Onkure Therapeutics, Inc.目标价做出预测，其中目标均价为31.50美元，其中最低目标价为30.00美元，最高目标价为33.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250312110259a1d6fb62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250312110259a1d6fb62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OKUR","LENZ"],"gpt_icon":0},{"id":"2518746364","title":"奥本海默：维持OnKure Therapeutics(OKUR.US)评级，由优于大市调整至优于大市评级, 目标价由35.00美元调整至30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518746364","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518746364?lang=zh_cn&edition=fundamental","pubTime":"2025-03-11 20:41","pubTimestamp":1741696890,"startTime":"0","endTime":"0","summary":"奥本海默：维持OnKure Therapeutics(OKUR.US)评级，由优于大市调整至优于大市评级, 目标价由35.00美元调整至30.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11204148668013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","OKUR"],"gpt_icon":0},{"id":"2518789118","title":"OnKure Therapeutics(OKUR.US)：2024年Q4财报实现营收0美元；每股收益为-1.37美元，前值为-30.14美元，预期值为-0.74美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518789118","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518789118?lang=zh_cn&edition=fundamental","pubTime":"2025-03-11 05:45","pubTimestamp":1741643101,"startTime":"0","endTime":"0","summary":"OnKure Therapeutics(OKUR.US)：2024年Q4财报实现营收0美元；每股收益为-1.37美元，前值为-30.14美元，预期值为-0.74美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11054548643205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","OKUR"],"gpt_icon":0},{"id":"1104892081","title":"OnKure Therapeutics 2024年第四季度GAAP每股收益$(1.37)未达到$(0.74)的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1104892081","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104892081?lang=zh_cn&edition=fundamental","pubTime":"2025-03-11 04:14","pubTimestamp":1741637672,"startTime":"0","endTime":"0","summary":"OnKure Therapeutics(LENZ) (NASDAQ:OKUR)报告的季度每股亏损为$(1.37)，未达到分析师普遍预期的$(0.74)，低于预期85.14%。以上内容来自Benzinga Earnings专栏，原文如下：OnKure $Therapeutics(LENZ)$ (NASDAQ:OKUR) reported quarterly losses of $(1.37) per share which missed the analyst consensus estimate of $(0.74) by 85.14 percent.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","OKUR"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OKUR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-10","symbol":"OKUR","fiscalQuarterEnding":"2024/12","expectedEps":-0.86,"name":null,"time":"盘后","type":"earning","dateTimestamp":1741579200000,"reportTimeType":"post","actualEps":-1.37}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OKUR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OKUR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1738123200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OKUR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OKUR","date":"2025-04-23","current":-0.663208,"percent":0.937984,"low":-5.826698,"twenty":-4.478884,"median":-1.720925,"eighty":-1.174736,"high":-0.566743,"avg":-2.420254,"sd":1.594054,"marketCap":34933147},"quantilePoints":[{"date":"2024-10-18","current":-0.566743,"twenty":-0.590487,"median":-0.58695,"eighty":-0.578615,"marketCap":23873500},{"date":"2024-10-25","current":-5.440362,"twenty":-1.566804,"median":-0.588529,"eighty":-0.583857,"marketCap":229169826},{"date":"2024-10-31","current":-5.53853,"twenty":-5.51383,"median":-0.595209,"eighty":-0.585182,"marketCap":233305021},{"date":"2024-11-08","current":-5.443529,"twenty":-5.51383,"median":-5.168028,"eighty":-0.586445,"marketCap":229303220},{"date":"2024-11-15","current":-5.044864,"twenty":-5.465063,"median":-5.164656,"eighty":-0.588845,"marketCap":225434812},{"date":"2024-11-22","current":-4.773218,"twenty":-5.441629,"median":-5.044864,"eighty":-0.591244,"marketCap":213296014},{"date":"2024-11-29","current":-4.603066,"twenty":-5.421362,"median":-4.955311,"eighty":-0.594567,"marketCap":205692591},{"date":"2024-12-06","current":-4.23888,"twenty":-5.387795,"median":-4.77471,"eighty":-2.052213,"marketCap":189418599},{"date":"2024-12-13","current":-3.232892,"twenty":-5.327258,"median":-4.623962,"eighty":-3.414388,"marketCap":144465030},{"date":"2024-12-20","current":-2.403027,"twenty":-5.244271,"median":-4.603066,"eighty":-2.584523,"marketCap":107381670},{"date":"2024-12-27","current":-2.444819,"twenty":-5.224724,"median":-4.480676,"eighty":-2.411385,"marketCap":109249178},{"date":"2025-01-03","current":-2.543328,"twenty":-5.168028,"median":-4.415003,"eighty":-2.435864,"marketCap":113651159},{"date":"2025-01-10","current":-2.331384,"twenty":-5.162633,"median":-4.235895,"eighty":-2.394669,"marketCap":104180229},{"date":"2025-01-17","current":-1.794061,"twenty":-5.159079,"median":-4.098579,"eighty":-2.308697,"marketCap":80169421},{"date":"2025-01-24","current":-1.605998,"twenty":-5.09033,"median":-3.232892,"eighty":-1.908093,"marketCap":71765638},{"date":"2025-01-31","current":-1.740329,"twenty":-5.041282,"median":-2.694077,"eighty":-1.735553,"marketCap":77768340},{"date":"2025-02-07","current":-1.698537,"twenty":-4.988744,"median":-2.570194,"eighty":-1.722418,"marketCap":75900833},{"date":"2025-02-14","current":-1.680626,"twenty":-4.917698,"median":-2.540343,"eighty":-1.700328,"marketCap":75100472},{"date":"2025-02-21","current":-1.629879,"twenty":-4.846055,"median":-2.485118,"eighty":-1.698537,"marketCap":72832785},{"date":"2025-02-28","current":-1.459727,"twenty":-4.775009,"median":-2.435864,"eighty":-1.629879,"marketCap":65229362},{"date":"2025-03-07","current":-1.510474,"twenty":-4.72068,"median":-2.35825,"eighty":-1.588087,"marketCap":67497050},{"date":"2025-03-14","current":-1.170006,"twenty":-4.634708,"median":-2.331384,"eighty":-1.520623,"marketCap":61627741},{"date":"2025-03-21","current":-1.2754,"twenty":-4.622768,"median":-2.038842,"eighty":-1.494951,"marketCap":67179130},{"date":"2025-03-28","current":-1.196325,"twenty":-4.613812,"median":-1.835853,"eighty":-1.463309,"marketCap":63014023},{"date":"2025-04-04","current":-0.992261,"twenty":-4.603066,"median":-1.777643,"eighty":-1.2754,"marketCap":52265363},{"date":"2025-04-11","current":-0.755037,"twenty":-4.555304,"median":-1.746299,"eighty":-1.238668,"marketCap":39770044},{"date":"2025-04-17","current":-0.747384,"twenty":-4.482467,"median":-1.737344,"eighty":-1.209875,"marketCap":39366970},{"date":"2025-04-23","current":-0.663208,"twenty":-4.478884,"median":-1.720925,"eighty":-1.174736,"marketCap":34933147}],"updateTime":1745504825300}}}